Literature DB >> 19591

Evaluation of copper complexes as potential anti-arthritic drugs.

J R Sorenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19591     DOI: 10.1111/j.2042-7158.1977.tb11367.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

1.  The pharmacologic activity of complexes and mixtures with copper and salicylates or aminopyrine following oral dosing in rats.

Authors:  Z Korolkiewicz; E Hać; I Gagało; P Gorczyca; A Lodzińska
Journal:  Agents Actions       Date:  1989-03

2.  Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells.

Authors:  C Broadley; R L Hoover
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

3.  Carrageenan oedema in copper-deficient rats.

Authors:  R Milanino; S Mazzoli; E Passarella; G Tarter; G P Velo
Journal:  Agents Actions       Date:  1978-12

Review 4.  Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders.

Authors:  R Milanino; A Conforti; L Franco; M Marrella; G Velo
Journal:  Agents Actions       Date:  1985-09

5.  Anti-inflammatory activity of a dermally applied copper salicylate preparation (Alcusal).

Authors:  W R Walker; S J Beveridge; M W Whitehouse
Journal:  Agents Actions       Date:  1980-04

6.  Copper and ceruloplasmin (Cp) concentrations during the acute inflammatory process in the rat.

Authors:  A Conforti; L Franco; R Milanino; G P Velo
Journal:  Agents Actions       Date:  1982-07

7.  Schiff base complexes of copper and zinc as potential anti-colitic compounds.

Authors:  Elaine M Conner; John Reglinski; W Ewen Smith; I Jack Zeitlin
Journal:  Biometals       Date:  2017-04-19       Impact factor: 2.949

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.